Heart valve structure: A predisposing factor for rheumatic heart disease [5]

Heart

Volumn 92, Issue 8, 2006, Pages 1151-1152

  Nayar, Sushma ^a,b   Nayar, P G ^a   Cherian, K M ^a  

^a International Centre for Cardio Thoracic and Vascular Diseases   (India)

^b Frontier Lifeline Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA VALVE; CONTROLLED STUDY; DISEASE PREDISPOSITION; HEART VALVE; HUMAN; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; MITRAL VALVE; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE;

ADULT; AGED; AORTIC VALVE; HEART VALVE DISEASES; HUMANS; MIDDLE AGED; MITRAL VALVE; RHEUMATIC HEART DISEASE;

EID: 33746429935     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.075358     Document Type: Letter

References (5)

1. Fischetti VA. Streptococcal M protein. Sci Am 1991;264:58-65.
2. Veasy LG, Hill HR. Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease. Pediatr Infect Dis J 1997;16:400-7.
3. Marcon MJ, Hribar MM, Hosier DM, et al. Occurrence of mucoid M18 Streptococcus pyogenes in a central Ohio pediatric population. J Clin Microbiol 1988;26:1539-42.
4. Stollerman GH. Current concepts of rheumatic fever. Internet J Cardiol, 2003;2(1).http://www.ispub.com/ostia/index.php?xmlFilePath = journals/ijc/vol2n1/rheumatic.xml (accessed 22 Feb 2006).
5. Moses AE, Wessels MR, Zalcman K, et al. Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A streptococcus. Infect Immun 1997;65:64-71.